Your browser doesn't support javascript.
loading
Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments.
Findlay-Wilson, Stephen; Easterbrook, Linda; Smith, Sandra; Pope, Neville; Aldridge, Matthew; Humphries, Gareth; Schuhmann, Holger; Ngabo, Didier; Rayner, Emma; Otter, Ashley; Coleman, Thomas; Hicks, Bethany; Halkerston, Rachel; Apostolakis, Kostis; Taylor, Stephen; Fotheringham, Susan; Horton, Amanda; CanoCejas, Irene; Wand, Matthew; Tree, Julia A; Sutton, Mark; Graham, Victoria; Hewson, Roger; Dowall, Stuart.
Affiliation
  • Findlay-Wilson S; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Easterbrook L; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Smith S; International Therapeutic, Proteins Ltd, Longford, TAS, 7301, Australia.
  • Pope N; International Therapeutic Proteins Ltd, Goleigh Farm, Hampshire, Selborne, GU34 3SE, UK.
  • Aldridge M; MicroPharm Ltd, Station Road, Newcastle Emlyn, SA38 9BY, UK.
  • Humphries G; Native Antigen Company, Langford Locks, Kidlington, Oxford, OX5 1LH, UK.
  • Schuhmann H; Native Antigen Company, Langford Locks, Kidlington, Oxford, OX5 1LH, UK.
  • Ngabo D; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Rayner E; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Otter A; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Coleman T; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Hicks B; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Halkerston R; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Apostolakis K; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Taylor S; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Fotheringham S; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Horton A; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • CanoCejas I; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Wand M; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Tree JA; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Sutton M; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Graham V; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Hewson R; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
  • Dowall S; UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. stuart.dowall@ukhsa.gov.uk.
Sci Rep ; 13(1): 15419, 2023 Sep 18.
Article in En | MEDLINE | ID: mdl-37723274
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Sci Rep Year: 2023 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Sci Rep Year: 2023 Type: Article Affiliation country: United kingdom